Home > Boards > US Listed > Medical - Drugs > Urigen Pharmaceuticals

Urigen completes 1:5000 reverse split and other changes:

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 752
Posts 116,010
Boards Moderated 12
Alias Born 09/05/02
160x600 placeholder
Top Company News of the Day
Mining company Rio Tinto named Peter Cunningham as chief financial officer, making permanent a role the company veteran has held on an interim basis since Jan 1.
Adobe's 3Q Guidance Ahead of Wall Street Targets
Adobe's 2Q Profit, Revenue Results Beat Wall Street Expectations
Soybeans Plummet on Weather and Economic Fears
Front Month Nymex Natural Gas Rose 0.06% to Settle at $3.2530 -- Data Talk
Front Month Nymex RBOB Gasoline Fell 1.02% to Settle at $2.1342 -- Data Talk
Google Gives $50 Million in Grants to 10 HBCUs
Danaher on Pace for Largest Percent Increase Since April 2020 -- Data Talk
STOXX Europe 50 Index Ends 0.11% Higher at 3580.06 -- Data Talk
CAC-40 Index Ends 0.20% Higher at 6666.26 -- Data Talk
STOXX Europe 600 Index Ends 0.12% Lower at 459.33 -- Data Talk
EURO STOXX 50 Index Ends 0.15% Higher at 4158.14 -- Data Talk
DAX Ends 0.11% Higher at 15727.67 -- Data Talk
FTSE 100 Index Ends 0.44% Lower at 7153.43 -- Data Talk
Danone to Sell Plant-Based Vega Brand
FTSE 100 Closes Down on Mining Sector Losses
Nanox Imaging Shares Rise 15% on 510(k) Application for Imaging System
U.S. Leading Economic Index Increased in May -- The Conference Board
UK Agrees Truce With US on Airbus-Boeing Trade Dispute
FTSE Falls, Nomura Advises Selling Euro Vs Pound
Danaher to Buy Aldevron for About $9.6 Billion in Cash
AcelRx in Agreement with FDA On Dsuvia Promotional Materials Warning Letter
Turning Point Gets FDA Orphan Designation for TPX-0022 in Gastric Cancer
Agenus Gets FDA Priority Review of Balstilimab in Cervical Cancer
Grain Export Sales on Low Side of Expectations
Jobless Claims Rose Last Week, Pausing Downward Trend
DewDiligence Member Level  Friday, 07/04/14 03:30:06 PM
Re: urgp2011 post# 300
Post # of 304 
Urigen completes 1:5000 reverse split and other changes:

http://finance.yahoo.com/news/urigen-pharmaceuticals-announces-closing-restructuring-220337580.html

The reverse split is academic insofar as the shares do not trade on any public exchange; from the above PR:
Quote:
The company's Stock previously traded under the designation (URGP.PK) on the OTC Markets. The Company's registration was revoked by the SEC in October, 2012, and there is no longer a public market for its securities, stockholders will be prohibited from transferring or selling their shares except in exempt transactions that are in compliance with the United States and applicable state securities laws.

Shareholders who wish to effect any transfers or sales should consult with their own legal counsel to ensure compliance with all applicable law.



“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences